Team

Insightful. Experienced. Entrepreneurial.

PIC Therapeutics' team of passionate leaders, board members and advisors brings well over 100 years of combined biopharmaceutical experience in research and development, launching innovative companies and cultivating their growth, and delivering breakthrough medicines to patients. We have also assembled a network of strategic partnerships with leading consultants and contractors, allowing us to benefit from their scale to efficiently and expeditiously advance our program.

Bowdish V3 B&W 052-28971_5x5.jpg
chris vandeusen.jpg
Lisa%20Sturla_edited.jpg

VP & Chief Scientific Officer

 

Alan E. Walts, PhD, Executive Chair, Advent Life Sciences

Dr. Kathy Bowdish, President & CEO

Richard Peters, MD, PhD, Co-Founder

Belinda Termeer, Termeer Family Office, Harvard Medical School Board of Fellows

Gerhard Wagner, PhD, Scientific Co-Founder, Elkan Blout Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

 

Keith Flaherty, MD, Director of Clinical Research at the Cancer Center and Richard Saltonstall Endowed Chair in Oncology at Massachusetts General Hospital, and Professor of Medicine at Harvard Medical School

Dejan Juric, MD, Director of the Termeer Center for Targeted Therapies & Program Director of the Investigational Cancer Therapeutics Program at Mass General Hospital Cancer Center

Jennifer Petter, PhD, Founder and CSO, Arrakis

Nahum Sonenberg, PhD, Rosalind and Morris Goodman Cancer Centre, McGill

Yat Sun Or, PhD, CSO, Enanta Pharmaceuticals

Jan van Heek, MBA, Board Member, Amarin Corp, Minerva Neurosciences

Gerhard Wagner, PhD, Scientific Co-Founder, Elkan Blout Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School